GB8916813D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- GB8916813D0 GB8916813D0 GB898916813A GB8916813A GB8916813D0 GB 8916813 D0 GB8916813 D0 GB 8916813D0 GB 898916813 A GB898916813 A GB 898916813A GB 8916813 A GB8916813 A GB 8916813A GB 8916813 D0 GB8916813 D0 GB 8916813D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8916813A GB2233974A (en) | 1989-07-22 | 1989-07-22 | Dihydropyridine antiinflammatory agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8916813A GB2233974A (en) | 1989-07-22 | 1989-07-22 | Dihydropyridine antiinflammatory agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB8916813D0 true GB8916813D0 (en) | 1989-09-06 |
| GB2233974A GB2233974A (en) | 1991-01-23 |
Family
ID=10660485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8916813A Withdrawn GB2233974A (en) | 1989-07-22 | 1989-07-22 | Dihydropyridine antiinflammatory agent |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2233974A (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530141A (en) * | 1992-03-04 | 1996-06-25 | Center For Innovative Technology | 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| US5639782A (en) * | 1992-03-04 | 1997-06-17 | Center For Innovative Technology | Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
| US5434151A (en) * | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| US5358938A (en) * | 1992-07-13 | 1994-10-25 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| US5463083A (en) | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5792776A (en) * | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| CN1152013C (en) * | 2001-11-22 | 2004-06-02 | 张喜田 | Levo-amlodipine salt able to generate hydrate and its hydrate and preparation |
| CN116332832A (en) * | 2023-03-29 | 2023-06-27 | 安徽美致诚药业有限公司 | Maleic acid levo-amlodipine amorphous crystal form and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0100189B1 (en) * | 1982-07-22 | 1986-05-28 | Pfizer Limited | Dihydropyridine anti-ischaemic and antihypertensive agents |
| GB8804630D0 (en) * | 1988-02-27 | 1988-03-30 | Pfizer Ltd | Preparation of r-& s-amlodipine |
-
1989
- 1989-07-22 GB GB8916813A patent/GB2233974A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB2233974A (en) | 1991-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB8926512D0 (en) | Therapeutic agents | |
| AP9000234A0 (en) | Therapeutic nucleocides | |
| GB8906168D0 (en) | Therapeutic agents | |
| GB8907401D0 (en) | Therapeutic agents | |
| GB8917333D0 (en) | Therapeutic agents | |
| GB8918061D0 (en) | Therapeutic agents | |
| GB8929260D0 (en) | Therapeutic agents | |
| GB8916813D0 (en) | Therapeutic agents | |
| GB8903740D0 (en) | Therapeutic agents | |
| GB8926083D0 (en) | Therapeutic agents | |
| GB8918060D0 (en) | Therapeutic agents | |
| GB8908529D0 (en) | Therapeutic agents | |
| GB8905130D0 (en) | Therapeutic agents | |
| GB8918952D0 (en) | Therapeutic agents | |
| GB8926063D0 (en) | Therapeutic agents | |
| GB8801758D0 (en) | Therapeutic agents | |
| GB8923363D0 (en) | Therapeutic agents | |
| GB8905799D0 (en) | Therapeutic agents | |
| GB8918301D0 (en) | Therapeutic agents | |
| GB8914203D0 (en) | Therapeutic agents | |
| GB8917303D0 (en) | Therapeutic agents | |
| GB8918954D0 (en) | Therapeutic agents | |
| GB8923015D0 (en) | Therapeutic agents | |
| GB8916575D0 (en) | Therapeutic agents | |
| GB8918953D0 (en) | Therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |